SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
42.65 EUR
+0.28 (+0.66%)
Taking everything into account, SHL scores 5 out of 10 in our fundamental rating. SHL was compared to 65 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
SHL had positive earnings in each of the past 5 years.
SHL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.83%, SHL is doing good in the industry, outperforming 61.54% of the companies in the same industry.
SHL has a Return On Equity of 11.88%. This is in the better half of the industry: SHL outperforms 66.15% of its industry peers.
SHL has a Return On Invested Capital of 7.65%. This is comparable to the rest of the industry: SHL outperforms 60.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.72%.
The last Return On Invested Capital (7.65%) for SHL is above the 3 year average (6.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.65% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
SHL's Profit Margin of 9.17% is fine compared to the rest of the industry. SHL outperforms 63.08% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
SHL has a Operating Margin of 13.53%. This is comparable to the rest of the industry: SHL outperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
Looking at the Gross Margin, with a value of 38.63%, SHL is doing worse than 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
The number of shares outstanding for SHL has been increased compared to 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.99 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.99, SHL is in line with its industry, outperforming 44.62% of the companies in the same industry.
SHL has a debt to FCF ratio of 5.45. This is a neutral value as SHL would need 5.45 years to pay back of all of its debts.
The Debt to FCF ratio of SHL (5.45) is comparable to the rest of the industry.
SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating SHL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, SHL is doing worse than 67.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 1.99 |
ROIC/WACC1.2
WACC6.37%
2.3 Liquidity
A Current Ratio of 1.11 indicates that SHL should not have too much problems paying its short term obligations.
The Current ratio of SHL (1.11) is worse than 73.85% of its industry peers.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a Quick ratio of 0.79. This is in the lower half of the industry: SHL underperforms 73.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.17% over the past year.
Measured over the past years, SHL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.29% on average per year.
The Revenue has been growing slightly by 4.53% in the past year.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.85% on average per year.
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y9.45%
EPS Next 5Y8.79%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y5.31%
Revenue Next 5Y5.85%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.85 indicates a rather expensive valuation of SHL.
Based on the Price/Earnings ratio, SHL is valued cheaper than 86.15% of the companies in the same industry.
SHL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.41.
With a Price/Forward Earnings ratio of 16.71, SHL is valued correctly.
69.23% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, SHL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.85 | ||
| Fwd PE | 16.71 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 66.15% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaply inside the industry as 87.69% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.73 | ||
| EV/EBITDA | 13.39 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.63
PEG (5Y)1.58
EPS Next 2Y9.66%
EPS Next 3Y9.45%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.22%.
Compared to an average industry Dividend Yield of 2.15, SHL pays a better dividend. On top of this SHL pays more dividend than 81.54% of the companies listed in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.22% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.72% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y9.66%
EPS Next 3Y9.45%
FRA:SHL (12/4/2025, 5:36:15 PM)
42.65
+0.28 (+0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.11B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts82.96
Price Target57.22 (34.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.22% |
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-7.54%
PT rev (3m)-7.54%
EPS NQ rev (1m)-9.25%
EPS NQ rev (3m)-9.25%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.51%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.85 | ||
| Fwd PE | 16.71 | ||
| P/S | 2.06 | ||
| P/FCF | 17.73 | ||
| P/OCF | 13.62 | ||
| P/B | 2.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.39 |
EPS(TTM)2.39
EY5.6%
EPS(NY)2.55
Fwd EY5.98%
FCF(TTM)2.41
FCFY5.64%
OCF(TTM)3.13
OCFY7.34%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)2.63
PEG (5Y)1.58
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.65% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 43.54% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.23% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.99 |
F-Score8
WACC6.37%
ROIC/WACC1.2
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y9.45%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y5.31%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year40.06%
EBIT Next 3Y17.45%
EBIT Next 5Y14.02%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 17.85 and the Price/Book (PB) ratio is 2.67.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.